Works by Iranzo, Eva
Results: 2
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.
- Published in:
- Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01205-5
- By:
- Publication type:
- Article
Severity and organ distribution of graft‐versus‐host disease with post‐transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA‐matched or single‐allele mismatched stem cell transplantation
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 6, p. 776, doi. 10.1111/ejh.14294
- By:
- Publication type:
- Article